PharmEasy’s parent API Holdings has also delayed internal plans for a potential initial public offering (IPO) to 2025, the people privy to the goings-on at the company said on condition of anonymity.from Tech-Economic Times https://ift.tt/csgPl92
Tuesday, February 14, 2023
Exclusive | Not selling Thyrocare, will cut cash burn: PharmEasy founders to board
PharmEasy’s parent API Holdings has also delayed internal plans for a potential initial public offering (IPO) to 2025, the people privy to the goings-on at the company said on condition of anonymity.from Tech-Economic Times https://ift.tt/csgPl92
Subscribe to:
Post Comments (Atom)
-
The German cabinet will hold a secret session on Wednesday to discuss safeguard measures regarding the possible participation of China's...
-
The Devas shareholders are enforcing an International Chamber of Commerce arbitral award of $1.2 billion to Devas, owed by ISRO commercial a...
No comments:
Post a Comment